Literature DB >> 16965774

High prevalence of major cardiovascular risk factors in first-degree relatives of individuals with familial premature coronary artery disease--the GENECARD project.

Claire Hurrell1, Vincent Wietlisbach, Valerie Jotterand, Marianne Volet, Vincent Lenain, Pascal Nicod, Roger Darioli, Fred Paccaud, Gerard Waeber, Vincent Mooser.   

Abstract

BACKGROUND: Hypertension, hypercholesterolemia, obesity and smoking are highly prevalent among patients with familial premature coronary artery disease (FP-CAD). Whether these risk factors equally affect other family members remains unknown.
METHODS: We examined 222 FP-CAD patients, 158 unaffected sibs, 197 offspring and 94 spouses in 108 FP-CAD families (> or = 2 sibs having survived CAD diagnosed before age 51 (M)/56 (F)), and compared them to population controls.
RESULTS: Unaffected sibs had a higher prevalence of hypertension (49% versus 24%, p<0.001), hypercholesterolemia (47% versus 34%, p=0.002), abdominal obesity (35% versus 24%, p=0.006) and smoking (39% versus 24%, p=0.001) than population controls. Offspring had a higher prevalence of hypertension (females), hypercholesterolemia and abdominal obesity than population controls. No difference was observed between spouses and controls. Compared to unaffected sibs, FP-CAD affected sibs had a similar risk factor profile, except for smoking, which was more prevalent (76% versus 39%, p=0.008).
CONCLUSIONS: Hypertension, obesity and hypercholesterolemia are highly prevalent among first-degree relatives, but not spouses, of patients with FP-CAD. These persons deserve special medical attention due to their familial/genetic susceptibility to atherogenic metabolic abnormalities. In these families, smoking may be the trigger for FP-CAD.

Entities:  

Mesh:

Year:  2006        PMID: 16965774     DOI: 10.1016/j.atherosclerosis.2006.08.004

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  7 in total

1.  Complex trait genetics the role of mechanistic "intermediate phenotypes" and candidate genetic loci.

Authors:  Fangwen Rao; Lian Zhang; Daniel T O'Connor
Journal:  J Am Coll Cardiol       Date:  2008-07-08       Impact factor: 24.094

2.  Motivational interviewing to support modifiable risk factor change in individuals at increased risk of cardiovascular disease: A systematic review and meta-analysis.

Authors:  Justin Lee Mifsud; Joseph Galea; Joanne Garside; John Stephenson; Felicity Astin
Journal:  PLoS One       Date:  2020-11-11       Impact factor: 3.240

3.  Disparity in risk factor pattern in premature versus late-onset coronary artery disease: a survey of 15,381 patients.

Authors:  Rona Reibis; Andras Treszl; Karl Wegscheider; Kurt Bestehorn; Barbara Karmann; Heinz Völler
Journal:  Vasc Health Risk Manag       Date:  2012-08-17

Review 4.  Familial hypercholesterolemia: A review.

Authors:  Mithun J Varghese
Journal:  Ann Pediatr Cardiol       Date:  2014-05

5.  Family History of Premature Coronary Artery Disease (P-CAD)-A Non-Modifiable Risk Factor? Dietary Patterns of Young Healthy Offspring of P-CAD Patients: A Case-Control Study (MAGNETIC Project).

Authors:  Tadeusz Osadnik; Natalia Pawlas; Marta Lonnie; Kamila Osadnik; Mateusz Lejawa; Lidia Wądołowska; Kamil Bujak; Martyna Fronczek; Rafał Reguła; Marcin Gawlita; Joanna Katarzyna Strzelczyk; Marta Góral; Marek Gierlotka; Lech Poloński; Mariusz Gąsior
Journal:  Nutrients       Date:  2018-10-12       Impact factor: 5.717

6.  High progesterone levels are associated with family history of premature coronary artery disease in young healthy adult men.

Authors:  Tadeusz Osadnik; Natalia Pawlas; Kamila Osadnik; Kamil Bujak; Marta Góral; Mateusz Lejawa; Martyna Fronczek; Rafał Reguła; Hanna Czarnecka; Marcin Gawlita; Joanna Katarzyna Strzelczyk; Małgorzata Gonera; Marek Gierlotka; Lech Poloński; Mariusz Gąsior
Journal:  PLoS One       Date:  2019-04-15       Impact factor: 3.240

7.  Coronary risk reduction intervention for siblings and offspring of patients with premature coronary heart disease: the CRISO study protocol for a randomised controlled pilot study.

Authors:  Justin Lee Mifsud; John Stephenson; Felicity Astin; Joseph Galea
Journal:  Pilot Feasibility Stud       Date:  2021-08-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.